FDA-AACR-IASLC Workshop to Address Tobacco Use Assessment in Clinical Trials
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
By Carmine S. Leggett, PhD Clinical trials in oncology have changed the face of cancer treatment, allowing cancer researchers...
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Building on advances in technology and analytical tools, real-world data (RWD) sources have attracted increasing interest as means to...
On September 6, 2018, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research hosted...
“We are in a promising time for cancer research and treatment; however, ovarian cancer remains difficult to treat, since...